Thank you for the thoughtful and comprehensive review of the presidential
symposium in the article "Experts Call for New Ways to Collaborate With
Pharma" in the July 3 issue. For one who wasn't at APA's 2009 annual
meeting, what was conveyed was informative and encouraging. I have found it
interesting that in my new part-time work as a prison psychiatrist, I have
found the use of older antidepressants and antipsychotics to be generally
quite satisfactory in many cases.
I would like to make an additional point. It is clear that our field has
become more biological, and more and more psychiatrists tend to do 15-minute
med checks. As Dr. Steven Sharfstein once said during his presidency, the
biopsychosocial model has become the bio-bio-bio model. My sense is that the
strong influence of pharma was one of the major factors, in addition to
managed care and reimbursement issues, that led to this change. I doubt that
just changing our relationship to pharma will head us back in the other
direction. What can we now do to reestablish us as biopsychosocial
H. STEVEN MOFFIC, M.D.